Tumor/disorder type | Animal models | Results | References |
---|---|---|---|
Gastric cancer | Immunodeficient BABL/c female nude mice | ↑ LINC01133: ↓ GC progression and ↓ metastasis | [21] |
Tumor-bearing nude mice | ↑ LINC01133: ↓ tumor growth | [22] | |
Epithelial ovarian cancer | Female athymic BALB/c nude mice | ↑ LINC01133: ↑ metastasis | [14] |
Ovarian cancer | Female BALB/c nude mice | ∆ LINC01133: ↑ tumor weight, ↑ tumor volume, ↑ metastasis | [15] |
Hepatocellular carcinoma | Female BALB/c nude mice | ∆ LINC01133: ↓ tumor weight, ↓ PI3K/AKT signaling activity | [23] |
Male BALB/c nu/nu mice | ↑ LINC01133: ↑ tumor volume, ↑ metastasis | [19] | |
Breast cancer | Female nude mice | ∆ LINC01133: ↑ metastasis | [25] |
Nasopharyngeal carcinoma | Immunodeficient male BALB/c nude mice | ↑ LINC01133: ↓ metastasis | [26] |
Renal cell carcinoma | Female nude BALB/7 mice | ∆ LINC01133: ↓ tumor weight, ↓ tumor volume | [27] |
Pancreatic cancer | BALB/c nude mice | ∆ LINC01133: ↓ tumor weight, ↓ proliferation | [29] |
Male BALB/c-nu nude mice | ↑ LINC01133: ↑ tumor weight, ↑ metastasis ∆ LINC01133: ↓ tumor weight, ↓ metastasis | [18] | |
SCID mice | ↑ miR-216a -5p (a target of LINC01133): ↓ tumor weight, ↓ metastasis | [30] | |
Male immunodeficient BALB/c nude mice | ∆ LINC01133: ↓ tumor growth, ↓ tumor weight and ↓ tumor volume | [31] | |
Colorectal cancer | Male NOD–SCID–gamma mice | ∆ LINC01133: ↑ metastasis | [34] |
Lung cancer | Female athymic BALB/c nude mice | ∆ LINC01133: ↓ tumor weight, ↓ tumor growth | [20] |
Bladder cancer | Male BALB/c-nu mice | ↑ LINC01133: ↓ tumor growth | [36] |